AzTrials
AzTrials

SHOULDER ARTHROPLASTYPROTECTNCT05699031

Shoulder Prosthesis Telerehab Care Trial

A study testing APP and PHYSICAL THERAPY in people with SHOULDER ARTHROPLASTY and REHABILITATION, run by University Hospital, Ghent at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to compare the rehabilitation by use of a smartphone-app with the usual care of physical therapy in patients, 60 years and older, who underwent a primary shoulder arthroplasty. Read more about this study

Who is it for?
Ages 60 years and older
What is being tested?
APP and PHYSICAL THERAPY
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteBelgium
Study dates
1 Mar 2023to 30 Sep 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 60 years and older
  • primary total shoulder arthroplasty (anatomical and reverse)
  • osteoarthritis, cuff tear arthropathy, pseudoparalysis
  • return home after discharge from hospital
  • no brace after surgery
  • sufficient verbal and written comprehension
  • hospitalization insurance

Who cannot join

  • revision arthroplasty
  • arthroplasty for fracture or tumor
  • neurological disease (parkinson, stroke, ...)
  • no access to smartphone, tablet or internet connectivity

Trial locations and contacts

1 site in 1 country.

Dominiek Vandenbosch, MSc contact

+32 9 332 16 69

dominiek.vandenbosch@ugent.be

Belgium1 site, 1 recruiting
  • Ghent University Hospital

    Ghent, 9000

    Alexander Van Tongel, MD, PHD

    Dominiek Vandenbosch, MSc, dominiek.vandenbosch@ugent.be

    Recruiting

Other trials in Belgium

About this study

Official title: The PROTECT-study: Home-based Telerehabilitation in the Post-operative Care After Shoulder Arthroplasty Compared to Usual Care: a Randomized Control Trial

The goal of this clinical trial is to compare the rehabilitation by use of a smartphone-app with the usual care of physical therapy in patients, 60 years and older, who underwent a primary shoulder arthroplasty.

The main questions it aims to answer are:

  • is the outcome of rehabilitation with the app as good as the usual care?
  • is the outcome for both types of shoulder arthroplasty similar?
  • what is the usability of the app?.

Participants will

  • have treatment according to the group they are allocated to
  • fill in questionnaires at specific moments during the rehabilitation stage (0 - 3 months ) and at 1 year post-surgery
Being tested
APP, PHYSICAL THERAPY
Keywords
SHOULDER ARTHROPLASTY, REHABILITATION, TELEREHABILITATION

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • APPDevice

    Patients allocated in the app-group will use the newly developed smartphone app te rehabilitate. 5 exercises are provided daily. Daily questionnaires will monitor exercise performance, VAS pain, household activities. Information modules will be sent at specific times.

  • PHYSICAL THERAPYOther

    Also called PHYSIO-GROUP

    Patients allocated in the physio-group will go, twice a week, to a physical therapist of their choice to rehabilitate. The physical therapist will follow the general guidelines provided by the hospital (surgeon).

Study groups in NCT05699031
Study groupRoleWhat they receive
APP-GROUPExperimentalPatients allocated in the app-group will use the app to rehabilitate.
Receives: Device: APP
PHYSIO-GROUPActive comparatorPatients allocated in the physio-group will rehabilitate according to the usual care protocol
Receives: Other: PHYSICAL THERAPY

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. SHOULDER PAIN AND DISABILITY INDEX (SPADI)_baseline pre-operative

    Content: 5 questions for the subscale pain and 8 questions for the disability subscale.

    Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.

    Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder

    Measured: Prior to surgery

  2. SHOULDER PAIN AND DISABILITY INDEX (SPADI)_baseline post-operative

    Content: 5 questions for the subscale pain and 8 questions for the disability subscale.

    Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.

    Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder

    Measured: week 0

  3. SHOULDER PAIN AND DISABILITY INDEX (SPADI)

    Content: 5 questions for the subscale pain and 8 questions for the disability subscale.

    Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.

    Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder

    Measured: week 3

  4. SHOULDER PAIN AND DISABILITY INDEX (SPADI)

    Content: 5 questions for the subscale pain and 8 questions for the disability subscale.

    Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.

    Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder

    Measured: week 6

  5. SHOULDER PAIN AND DISABILITY INDEX (SPADI)

    Content: 5 questions for the subscale pain and 8 questions for the disability subscale.

    Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.

    Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder

    Measured: week 12

  6. SHOULDER PAIN AND DISABILITY INDEX (SPADI)

    Content: 5 questions for the subscale pain and 8 questions for the disability subscale.

    Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.

    Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder

    Measured: week 52

Secondary outcomes (13)
  1. ACTIVE MOBILITY (ROM) OF THE SHOULDER

    ACTIVE ROM: forward flexion and abduction with extended elbow, functional internal and external rotation in standing position.

    • maximal pain free ROM
    • forward flexion and abduction with extended elbow: measured with the EasyAngle (Meloq AB Sweden)
    • hand-to-back and hand-nek test : scored as in Constant-Murley Score
    1. PASSIVE: forward flexion, abduction, external and internal rotation in supine position.
    • maximal pain free ROM
    • forward flexion and abduction: measured with the EasyAngle (Meloq AB Sweden)
    • rotations: measured as ER1 (arm at the side)/ ER2 (arm in 90° abduction) and IR1 (arm in 90° forward flexion)/ IR2 (arm in 90° abduction) with the EasyAngle (Meloq AB Sweden).

    Measured: Prior to surgery, week 3, week 6, week 12, week 52

  2. PASSIVE MOBILITY (ROM) OF THE SHOULDER

    PASSIVE: forward flexion, abduction, external and internal rotation in supine position.

    • maximal pain free ROM
    • forward flexion and abduction: measured with the EasyAngle (Meloq AB Sweden)
    • rotations: measured as ER1 (arm at the side)/ ER2 (arm in 90° abduction) and IR1 (arm in 90° forward flexion)/ IR2 (arm in 90° abduction) with the EasyAngle (Meloq AB Sweden).

    Measured: Prior to surgery, week 3, week 6, week 12, week 52

  3. STRENGTH

    Forward flexion, extension, ab- and adduction, external and internal rotation.

    • isometrical contraction for 5 seconds, 3 repetitions, 30 sec break in between
    • measured with EasyForce (Meloq AB Sweden)
    • seated, both feet on the ground, back against backrest
    • elbow flexed (90°) held at side, fist forward, thumb upward

    Measured: Prior to surgery, week 3, week 6, week 12, week 52

  4. CONSTANT-MURLEY SCORE

    Content: partially clinical (65 points) and partially PROM (35 points) assessed.

    Scoring: The formula to calculate the total score is:" pain (0-15) + ADL (4x (0-5) = 0-20) + mobility (4 x (0-10) = 0-40) + strength (0 -25)". Strength will be measured with the arm elevated to 90 ° in the scapular plane using an IDOmeter.

    Interpretation: 0-55 points = bad, 56-70 points = mediocre, 71-85 points = good, 86-100 points = excellent score

    Measured: Prior to surgery, week 3, week 6, week 12, week 52

  5. ACTIVITIES OF DAILY LIVING EXTERNAL AND INTERNAL ROTATIONS (ADLEIR)

    Content: 12 questions about specific ADL tasks that require external or internal rotation while performing.

    Scoring: Each activity is scored between 0 (unable to do) and 3 (not difficult at all). All activities should be performed without the help of flexing the neck or bending the trunk and without the help of first abducting the elbow (i.e., without doing a hornblower sign).

    Interpretation: The maximal score is 36. A higher score means that the patient is able to perform ADL activities with enough strength in external and internal rotation

    Measured: Prior to surgery, week 3, week 6, week 12, week 52

  6. SINGLE ASSESSMENT NUMERIC EVALUATION (SANE)

    Content: 1 question: 'how would you rate your shoulder today as a percentage of normal?'.

    Scoring: percentage between 0 and 100% Interpretation: 100% being a normal shoulder.

    Measured: Prior to surgery, week 3, week 6, week 12, week 52

  7. EUROQOL 5-DIMENSIONS 5-LEVEL (EQ-5D-5L)

    Content: 5 questions + EQ-5D VAS for general health. Scoring: 5-response scale (from 'no problems' to 'extreme problems') + VAS percentage between 0 (worst imaginable health state) and 100 (best imaginable health state).

    Interpretation: VAS score for general health indicates how a patient perceives his general health, Other questions are descriptive for problems in mobility, self-care, usual activities, pain/ discomfort, anxiety/depression.

    Measured: Prior to surgery, week 3, week 6, week 12, week 52

  8. GRONINGEN ACTIVITY RESTRICTION SCALE (GARS-4)

    Content: 18 questions to identify problems with self-sufficiency in self-care and housekeeping. Patients do not respond if they do that activity but rather if they could do that activity.

    Scoring: ordinal scale from 1 (Yes, I can do that on my own without any effort) up to 4 (No, I can't do that on my own, but only with the help of others).

    Interpretation: A higher score (max 72) is related to a lower self-sufficiency.

    Measured: Prior to surgery, week 3, week 6, week 12, week 52

  9. EXERCISE ADHERENCE RATING SCALE (EARS)

    Content: 3 sections section A: 6 questions to evaluate the prescribed exercises. section B: 6 questions on how a patient does the recommended exercises or activities.

    section C: 10 statements on why a patient does or does not do the recommended exercises or activities.

    Scoring: sections B and C: 5-point Likert scale (0 - 4) (some questions scored reversed).

    Interpretation:

    section B (range 0 - 24): a higher score indicates a better compliance/adherence .

    section C (range 0 - 40): a higher score indicates a better adherence.

    Measured: Prior to surgery, week 3, week 6, week 12, week 52

  10. EXERCISE DIARY

    Content: performed exercises, household activities, VAS pain. Diary on paper for physio-group, by the app for the app-group.

    Measured: Daily post-surgery (week 0 - week 12)

  11. SELF-EFFICACY FOR EXERCISES (SEE)

    Content: 9 questions about 'confidence in engaging in exercise 3 times a week for 20 minutes if faced with a barrier'.

    Scoring: 'not very confident' (0) and 'very confident' (10). Interpretation: The higher the score , the patient feel more confident in performing prescribed exercises.

    Measured: Week 3, week 6, week 12, week 52

  12. GLOBAL RATING OF CHANGE SCALE (GROC)

    Content: A single question (How would you currently describe the change in your operated shoulder compared to just before surgery) is scored on a scale, ranging from 'very much worse' through 'unchanged' to 'completely recovered'.

    Scoring: The scale used is divided in 11 points ( very much worse -5, the same 0, very much better + 5) Interpretation: the number given indicates how a patient perceives the change after surgery.

    Measured: Prior to surgery, week 3, week 6, week 12, week 52

  13. GLOBAL PERCEIVED EFFECT (GPE/GEE)

    Content: 2 questions: To what extent have you recovered from your symptoms?, How satisfied are you with your treatment?.

    Scoring: a 7-point rating scale. Interpretation: The higher the score , the better.

    Measured: Prior to surgery, week 3, week 6, week 12, week 52

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2023
  2. Study start1 Mar 2023
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion30 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05699031
Sponsor's protocol ID
ONZ-2022-0357
Acronym
PROTECT
Status last verified
Apr 2024
First submitted
23 Dec 2022
Last updated
12 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing APP and PHYSICAL THERAPY in people with SHOULDER ARTHROPLASTY and REHABILITATION, run by University Hospital, Ghent at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dominiek Vandenbosch, MSc (+32 9 332 16 69, dominiek.vandenbosch@ugent.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

SHOULDER PAIN AND DISABILITY INDEX (SPADI)_baseline pre-operative (time frame: Prior to surgery). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in